La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Manganese-induced apoptosis in PC12 cells

Identifieur interne : 001022 ( PascalFrancis/Corpus ); précédent : 001021; suivant : 001023

Manganese-induced apoptosis in PC12 cells

Auteurs : Yoko Hirata

Source :

RBID : Pascal:03-0018076

Descripteurs français

English descriptors

Abstract

Manganese has been known to induce neurological disorders similar to parkinsonisms for a long time. Dopamine deficiency has been demonstrated in Parkinson's disease and in chronic manganese poisoning, suggesting that the mechanisms underlying the neurotoxic effects of the metal ion are related to dysfunction of the extrapyramidal system. However, the details of the mechanisms have yet to be elucidated. In an effort to learn more about the toxicity of manganese, we have employed an in vitro model that uses the PC12 catecholaminergic cell line. In this model, manganese induces apoptosis in PC12 cells. In this paper, experiments conducted with this model, the cellular biochemical changes, and the mechanism of the cell death are reviewed.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0892-0362
A02 01      @0 NETEEC
A03   1    @0 Neurotoxicol. teratol.
A05       @2 24
A06       @2 5
A08 01  1  ENG  @1 Manganese-induced apoptosis in PC12 cells
A09 01  1  ENG  @1 Milestones in Research on Neurotoxins and Neuroprotection: A Tribute to Professor Toshiharu Nagatsu
A11 01  1    @1 HIRATA (Yoko)
A12 01  1    @1 NAOI (Makoto) @9 ed.
A12 02  1    @1 PARVEZ (Hasan) @9 ed.
A12 03  1    @1 MARUYAMA (Wakako) @9 ed.
A12 04  1    @1 COLLINS (Michel A.) @9 ed.
A12 05  1    @1 YOUDIM (Moussa B. H.) @9 ed.
A14 01      @1 Laboratory for Genes of Motor Systems, Bio-Mimetic Control Research Center, RIKEN, 2271-130, Anagahora, Shimoshidami @2 Moriyama, Nagoya 463-0003 @3 JPN @Z 1 aut.
A14 02      @1 Department of Biomolecular Science, Faculty of Engineering, Gifu University @2 Gifu 501-1193 @3 JPN @Z 1 aut.
A15 01      @1 Department of Brain Sciences, Institute of Applied Biochemistry, Yagi Memorial Park @2 Mitake, Gifu 505-0116 @3 JPN @Z 1 aut.
A15 02      @1 Unit of Neuroendocrinology, Bat. 5, Parc Chateau, CNRS @2 91190 Gif sur Yvette @3 FRA @Z 2 aut.
A15 03      @1 Laboratory of Biochemistry and Metabolism, Department of Basic Gerontology, National Institute of Longevity Sciences @2 Obu, Aichi 474-8622 @3 JPN @Z 3 aut.
A15 04      @1 Department of Molecular and Cellular Biochemistry, Loyola University of Chicago, Strich School of Medicine @2 Maywood, IL 60153 @3 USA @Z 4 aut.
A15 05      @1 Eve Topf and National Parkinson Foundation Neurodegenerative Diseases Centers, Department of Pharmacology, Rappaport Faculty of Medicine, Technion @2 Haifa 31096 @3 ISR @Z 5 aut.
A20       @1 639-653
A21       @1 2002
A23 01      @0 ENG
A43 01      @1 INIST @2 18910 @5 354000109244300090
A44       @0 0000 @1 © 2003 INIST-CNRS. All rights reserved.
A45       @0 68 ref.
A47 01  1    @0 03-0018076
A60       @1 P @2 C
A61       @0 A
A64 01  1    @0 Neurotoxicology and teratology
A66 01      @0 USA
C01 01    ENG  @0 Manganese has been known to induce neurological disorders similar to parkinsonisms for a long time. Dopamine deficiency has been demonstrated in Parkinson's disease and in chronic manganese poisoning, suggesting that the mechanisms underlying the neurotoxic effects of the metal ion are related to dysfunction of the extrapyramidal system. However, the details of the mechanisms have yet to be elucidated. In an effort to learn more about the toxicity of manganese, we have employed an in vitro model that uses the PC12 catecholaminergic cell line. In this model, manganese induces apoptosis in PC12 cells. In this paper, experiments conducted with this model, the cellular biochemical changes, and the mechanism of the cell death are reviewed.
C02 01  X    @0 002B17G
C03 01  X  FRE  @0 Manganèse @2 NC @5 01
C03 01  X  ENG  @0 Manganese @2 NC @5 01
C03 01  X  SPA  @0 Manganeso @2 NC @5 01
C03 02  X  FRE  @0 Métal lourd @5 04
C03 02  X  ENG  @0 Heavy metal @5 04
C03 02  X  SPA  @0 Metal pesado @5 04
C03 03  X  FRE  @0 Toxicité @5 07
C03 03  X  ENG  @0 Toxicity @5 07
C03 03  X  SPA  @0 Toxicidad @5 07
C03 04  X  FRE  @0 Parkinson maladie @5 10
C03 04  X  ENG  @0 Parkinson disease @5 10
C03 04  X  SPA  @0 Parkinson enfermedad @5 10
C03 05  X  FRE  @0 In vitro @5 11
C03 05  X  ENG  @0 In vitro @5 11
C03 05  X  SPA  @0 In vitro @5 11
C03 06  X  FRE  @0 Apoptose @5 12
C03 06  X  ENG  @0 Apoptosis @5 12
C03 06  X  SPA  @0 Apoptosis @5 12
C03 07  X  FRE  @0 Catécholamine @5 13
C03 07  X  ENG  @0 Catecholamine @5 13
C03 07  X  SPA  @0 Catecolamina @5 13
C03 08  X  FRE  @0 Déficit @5 14
C03 08  X  ENG  @0 Deficiency @5 14
C03 08  X  SPA  @0 Déficiencia @5 14
C03 09  X  FRE  @0 Dopamine @2 NK @2 FR @5 15
C03 09  X  ENG  @0 Dopamine @2 NK @2 FR @5 15
C03 09  X  SPA  @0 Dopamina @2 NK @2 FR @5 15
C03 10  X  FRE  @0 Pathogénie @5 16
C03 10  X  ENG  @0 Pathogenesis @5 16
C03 10  X  SPA  @0 Patogenia @5 16
C03 11  X  FRE  @0 Lignée PC12 @4 INC @5 86
C07 01  X  FRE  @0 Système nerveux pathologie @5 61
C07 01  X  ENG  @0 Nervous system diseases @5 61
C07 01  X  SPA  @0 Sistema nervioso patología @5 61
C07 02  X  FRE  @0 Système nerveux central pathologie @5 62
C07 02  X  ENG  @0 Central nervous system disease @5 62
C07 02  X  SPA  @0 Sistema nervosio central patología @5 62
C07 03  X  FRE  @0 Encéphale pathologie @5 63
C07 03  X  ENG  @0 Cerebral disorder @5 63
C07 03  X  SPA  @0 Encéfalo patología @5 63
C07 04  X  FRE  @0 Extrapyramidal syndrome @5 64
C07 04  X  ENG  @0 Extrapyramidal syndrome @5 64
C07 04  X  SPA  @0 Extrapiramidal síndrome @5 64
C07 05  X  FRE  @0 Maladie dégénérative @5 65
C07 05  X  ENG  @0 Degenerative disease @5 65
C07 05  X  SPA  @0 Enfermedad degenerativa @5 65
N21       @1 006
N82       @1 PSI
pR  
A30 01  1  ENG  @1 International Catecholamine Symposium @2 9 @3 Kyoto JPN @4 2001-03-31
A30 02  1  ENG  @1 International Joint Congresses on Progress in Alzheimer's and Parkinson's Disease @2 5 @3 Kyoto JPN @4 2001-03-31

Format Inist (serveur)

NO : PASCAL 03-0018076 INIST
ET : Manganese-induced apoptosis in PC12 cells
AU : HIRATA (Yoko); NAOI (Makoto); PARVEZ (Hasan); MARUYAMA (Wakako); COLLINS (Michel A.); YOUDIM (Moussa B. H.)
AF : Laboratory for Genes of Motor Systems, Bio-Mimetic Control Research Center, RIKEN, 2271-130, Anagahora, Shimoshidami/Moriyama, Nagoya 463-0003/Japon (1 aut.); Department of Biomolecular Science, Faculty of Engineering, Gifu University/Gifu 501-1193/Japon (1 aut.); Department of Brain Sciences, Institute of Applied Biochemistry, Yagi Memorial Park/Mitake, Gifu 505-0116/Japon (1 aut.); Unit of Neuroendocrinology, Bat. 5, Parc Chateau, CNRS/91190 Gif sur Yvette/France (2 aut.); Laboratory of Biochemistry and Metabolism, Department of Basic Gerontology, National Institute of Longevity Sciences/Obu, Aichi 474-8622/Japon (3 aut.); Department of Molecular and Cellular Biochemistry, Loyola University of Chicago, Strich School of Medicine/Maywood, IL 60153/Etats-Unis (4 aut.); Eve Topf and National Parkinson Foundation Neurodegenerative Diseases Centers, Department of Pharmacology, Rappaport Faculty of Medicine, Technion/Haifa 31096/Israël (5 aut.)
DT : Publication en série; Congrès; Niveau analytique
SO : Neurotoxicology and teratology; ISSN 0892-0362; Coden NETEEC; Etats-Unis; Da. 2002; Vol. 24; No. 5; Pp. 639-653; Bibl. 68 ref.
LA : Anglais
EA : Manganese has been known to induce neurological disorders similar to parkinsonisms for a long time. Dopamine deficiency has been demonstrated in Parkinson's disease and in chronic manganese poisoning, suggesting that the mechanisms underlying the neurotoxic effects of the metal ion are related to dysfunction of the extrapyramidal system. However, the details of the mechanisms have yet to be elucidated. In an effort to learn more about the toxicity of manganese, we have employed an in vitro model that uses the PC12 catecholaminergic cell line. In this model, manganese induces apoptosis in PC12 cells. In this paper, experiments conducted with this model, the cellular biochemical changes, and the mechanism of the cell death are reviewed.
CC : 002B17G
FD : Manganèse; Métal lourd; Toxicité; Parkinson maladie; In vitro; Apoptose; Catécholamine; Déficit; Dopamine; Pathogénie; Lignée PC12
FG : Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative
ED : Manganese; Heavy metal; Toxicity; Parkinson disease; In vitro; Apoptosis; Catecholamine; Deficiency; Dopamine; Pathogenesis
EG : Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease
SD : Manganeso; Metal pesado; Toxicidad; Parkinson enfermedad; In vitro; Apoptosis; Catecolamina; Déficiencia; Dopamina; Patogenia
LO : INIST-18910.354000109244300090
ID : 03-0018076

Links to Exploration step

Pascal:03-0018076

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Manganese-induced apoptosis in PC12 cells</title>
<author>
<name sortKey="Hirata, Yoko" sort="Hirata, Yoko" uniqKey="Hirata Y" first="Yoko" last="Hirata">Yoko Hirata</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Laboratory for Genes of Motor Systems, Bio-Mimetic Control Research Center, RIKEN, 2271-130, Anagahora, Shimoshidami</s1>
<s2>Moriyama, Nagoya 463-0003</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Biomolecular Science, Faculty of Engineering, Gifu University</s1>
<s2>Gifu 501-1193</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">03-0018076</idno>
<date when="2002">2002</date>
<idno type="stanalyst">PASCAL 03-0018076 INIST</idno>
<idno type="RBID">Pascal:03-0018076</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001022</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Manganese-induced apoptosis in PC12 cells</title>
<author>
<name sortKey="Hirata, Yoko" sort="Hirata, Yoko" uniqKey="Hirata Y" first="Yoko" last="Hirata">Yoko Hirata</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Laboratory for Genes of Motor Systems, Bio-Mimetic Control Research Center, RIKEN, 2271-130, Anagahora, Shimoshidami</s1>
<s2>Moriyama, Nagoya 463-0003</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Biomolecular Science, Faculty of Engineering, Gifu University</s1>
<s2>Gifu 501-1193</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Neurotoxicology and teratology</title>
<title level="j" type="abbreviated">Neurotoxicol. teratol.</title>
<idno type="ISSN">0892-0362</idno>
<imprint>
<date when="2002">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Neurotoxicology and teratology</title>
<title level="j" type="abbreviated">Neurotoxicol. teratol.</title>
<idno type="ISSN">0892-0362</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Apoptosis</term>
<term>Catecholamine</term>
<term>Deficiency</term>
<term>Dopamine</term>
<term>Heavy metal</term>
<term>In vitro</term>
<term>Manganese</term>
<term>Parkinson disease</term>
<term>Pathogenesis</term>
<term>Toxicity</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Manganèse</term>
<term>Métal lourd</term>
<term>Toxicité</term>
<term>Parkinson maladie</term>
<term>In vitro</term>
<term>Apoptose</term>
<term>Catécholamine</term>
<term>Déficit</term>
<term>Dopamine</term>
<term>Pathogénie</term>
<term>Lignée PC12</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Manganese has been known to induce neurological disorders similar to parkinsonisms for a long time. Dopamine deficiency has been demonstrated in Parkinson's disease and in chronic manganese poisoning, suggesting that the mechanisms underlying the neurotoxic effects of the metal ion are related to dysfunction of the extrapyramidal system. However, the details of the mechanisms have yet to be elucidated. In an effort to learn more about the toxicity of manganese, we have employed an in vitro model that uses the PC12 catecholaminergic cell line. In this model, manganese induces apoptosis in PC12 cells. In this paper, experiments conducted with this model, the cellular biochemical changes, and the mechanism of the cell death are reviewed.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0892-0362</s0>
</fA01>
<fA02 i1="01">
<s0>NETEEC</s0>
</fA02>
<fA03 i2="1">
<s0>Neurotoxicol. teratol.</s0>
</fA03>
<fA05>
<s2>24</s2>
</fA05>
<fA06>
<s2>5</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Manganese-induced apoptosis in PC12 cells</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG">
<s1>Milestones in Research on Neurotoxins and Neuroprotection: A Tribute to Professor Toshiharu Nagatsu</s1>
</fA09>
<fA11 i1="01" i2="1">
<s1>HIRATA (Yoko)</s1>
</fA11>
<fA12 i1="01" i2="1">
<s1>NAOI (Makoto)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1">
<s1>PARVEZ (Hasan)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="03" i2="1">
<s1>MARUYAMA (Wakako)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="04" i2="1">
<s1>COLLINS (Michel A.)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="05" i2="1">
<s1>YOUDIM (Moussa B. H.)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01">
<s1>Laboratory for Genes of Motor Systems, Bio-Mimetic Control Research Center, RIKEN, 2271-130, Anagahora, Shimoshidami</s1>
<s2>Moriyama, Nagoya 463-0003</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Department of Biomolecular Science, Faculty of Engineering, Gifu University</s1>
<s2>Gifu 501-1193</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA15 i1="01">
<s1>Department of Brain Sciences, Institute of Applied Biochemistry, Yagi Memorial Park</s1>
<s2>Mitake, Gifu 505-0116</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
</fA15>
<fA15 i1="02">
<s1>Unit of Neuroendocrinology, Bat. 5, Parc Chateau, CNRS</s1>
<s2>91190 Gif sur Yvette</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</fA15>
<fA15 i1="03">
<s1>Laboratory of Biochemistry and Metabolism, Department of Basic Gerontology, National Institute of Longevity Sciences</s1>
<s2>Obu, Aichi 474-8622</s2>
<s3>JPN</s3>
<sZ>3 aut.</sZ>
</fA15>
<fA15 i1="04">
<s1>Department of Molecular and Cellular Biochemistry, Loyola University of Chicago, Strich School of Medicine</s1>
<s2>Maywood, IL 60153</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA15>
<fA15 i1="05">
<s1>Eve Topf and National Parkinson Foundation Neurodegenerative Diseases Centers, Department of Pharmacology, Rappaport Faculty of Medicine, Technion</s1>
<s2>Haifa 31096</s2>
<s3>ISR</s3>
<sZ>5 aut.</sZ>
</fA15>
<fA20>
<s1>639-653</s1>
</fA20>
<fA21>
<s1>2002</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>18910</s2>
<s5>354000109244300090</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2003 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>68 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>03-0018076</s0>
</fA47>
<fA60>
<s1>P</s1>
<s2>C</s2>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Neurotoxicology and teratology</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Manganese has been known to induce neurological disorders similar to parkinsonisms for a long time. Dopamine deficiency has been demonstrated in Parkinson's disease and in chronic manganese poisoning, suggesting that the mechanisms underlying the neurotoxic effects of the metal ion are related to dysfunction of the extrapyramidal system. However, the details of the mechanisms have yet to be elucidated. In an effort to learn more about the toxicity of manganese, we have employed an in vitro model that uses the PC12 catecholaminergic cell line. In this model, manganese induces apoptosis in PC12 cells. In this paper, experiments conducted with this model, the cellular biochemical changes, and the mechanism of the cell death are reviewed.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Manganèse</s0>
<s2>NC</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Manganese</s0>
<s2>NC</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Manganeso</s0>
<s2>NC</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Métal lourd</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Heavy metal</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Metal pesado</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Toxicité</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Toxicity</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Toxicidad</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Parkinson maladie</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Parkinson disease</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Parkinson enfermedad</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>In vitro</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>In vitro</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>In vitro</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Apoptose</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Apoptosis</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Apoptosis</s0>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Catécholamine</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Catecholamine</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Catecolamina</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Déficit</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Deficiency</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Déficiencia</s0>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Dopamine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>15</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Dopamine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>15</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Dopamina</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>15</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Pathogénie</s0>
<s5>16</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Pathogenesis</s0>
<s5>16</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Patogenia</s0>
<s5>16</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>Lignée PC12</s0>
<s4>INC</s4>
<s5>86</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>61</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>61</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>61</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Système nerveux central pathologie</s0>
<s5>62</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>62</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>62</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Encéphale pathologie</s0>
<s5>63</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>63</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>63</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Extrapyramidal syndrome</s0>
<s5>64</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>64</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>64</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>65</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>65</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>65</s5>
</fC07>
<fN21>
<s1>006</s1>
</fN21>
<fN82>
<s1>PSI</s1>
</fN82>
</pA>
<pR>
<fA30 i1="01" i2="1" l="ENG">
<s1>International Catecholamine Symposium</s1>
<s2>9</s2>
<s3>Kyoto JPN</s3>
<s4>2001-03-31</s4>
</fA30>
<fA30 i1="02" i2="1" l="ENG">
<s1>International Joint Congresses on Progress in Alzheimer's and Parkinson's Disease</s1>
<s2>5</s2>
<s3>Kyoto JPN</s3>
<s4>2001-03-31</s4>
</fA30>
</pR>
</standard>
<server>
<NO>PASCAL 03-0018076 INIST</NO>
<ET>Manganese-induced apoptosis in PC12 cells</ET>
<AU>HIRATA (Yoko); NAOI (Makoto); PARVEZ (Hasan); MARUYAMA (Wakako); COLLINS (Michel A.); YOUDIM (Moussa B. H.)</AU>
<AF>Laboratory for Genes of Motor Systems, Bio-Mimetic Control Research Center, RIKEN, 2271-130, Anagahora, Shimoshidami/Moriyama, Nagoya 463-0003/Japon (1 aut.); Department of Biomolecular Science, Faculty of Engineering, Gifu University/Gifu 501-1193/Japon (1 aut.); Department of Brain Sciences, Institute of Applied Biochemistry, Yagi Memorial Park/Mitake, Gifu 505-0116/Japon (1 aut.); Unit of Neuroendocrinology, Bat. 5, Parc Chateau, CNRS/91190 Gif sur Yvette/France (2 aut.); Laboratory of Biochemistry and Metabolism, Department of Basic Gerontology, National Institute of Longevity Sciences/Obu, Aichi 474-8622/Japon (3 aut.); Department of Molecular and Cellular Biochemistry, Loyola University of Chicago, Strich School of Medicine/Maywood, IL 60153/Etats-Unis (4 aut.); Eve Topf and National Parkinson Foundation Neurodegenerative Diseases Centers, Department of Pharmacology, Rappaport Faculty of Medicine, Technion/Haifa 31096/Israël (5 aut.)</AF>
<DT>Publication en série; Congrès; Niveau analytique</DT>
<SO>Neurotoxicology and teratology; ISSN 0892-0362; Coden NETEEC; Etats-Unis; Da. 2002; Vol. 24; No. 5; Pp. 639-653; Bibl. 68 ref.</SO>
<LA>Anglais</LA>
<EA>Manganese has been known to induce neurological disorders similar to parkinsonisms for a long time. Dopamine deficiency has been demonstrated in Parkinson's disease and in chronic manganese poisoning, suggesting that the mechanisms underlying the neurotoxic effects of the metal ion are related to dysfunction of the extrapyramidal system. However, the details of the mechanisms have yet to be elucidated. In an effort to learn more about the toxicity of manganese, we have employed an in vitro model that uses the PC12 catecholaminergic cell line. In this model, manganese induces apoptosis in PC12 cells. In this paper, experiments conducted with this model, the cellular biochemical changes, and the mechanism of the cell death are reviewed.</EA>
<CC>002B17G</CC>
<FD>Manganèse; Métal lourd; Toxicité; Parkinson maladie; In vitro; Apoptose; Catécholamine; Déficit; Dopamine; Pathogénie; Lignée PC12</FD>
<FG>Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative</FG>
<ED>Manganese; Heavy metal; Toxicity; Parkinson disease; In vitro; Apoptosis; Catecholamine; Deficiency; Dopamine; Pathogenesis</ED>
<EG>Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease</EG>
<SD>Manganeso; Metal pesado; Toxicidad; Parkinson enfermedad; In vitro; Apoptosis; Catecolamina; Déficiencia; Dopamina; Patogenia</SD>
<LO>INIST-18910.354000109244300090</LO>
<ID>03-0018076</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001022 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001022 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:03-0018076
   |texte=   Manganese-induced apoptosis in PC12 cells
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024